The interleukin-1β modulator gevokizumab reduces neointimal proliferation and improves reendothelialization in a rat carotid denudation model.
Roubille F, Busseuil D, Shi Y, Nachar W, Mihalache-Avram T, Mecteau M, Gillis MA, Brand G, Théberge-Julien G, Brodeur MR, Kernaleguen AE, Gombos M, Rhéaume E, Tardif JC.
Roubille F, et al. Among authors: shi y.
Atherosclerosis. 2014 Oct;236(2):277-85. doi: 10.1016/j.atherosclerosis.2014.07.012. Epub 2014 Jul 21.
Atherosclerosis. 2014.
PMID: 25108619